CDKN2A and neoplasm: A recent study conducting genome analysis of clinical samples revealed that ASCs are likely to share the most common genomic mutations including KRAS, TP53, CDKN2A, and SMAD4, with PDACs, which supports the theory that these tumor types are derived from a common lineage [40].